626
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Oxaliplatin immunohybrid nanoparticles in vitro synergistic suppression evaluation in treatment of colorectal cancer

, &
Pages 261-269 | Received 19 Oct 2015, Accepted 21 Jan 2016, Published online: 02 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gamaleldin I. Harisa, Mohamed M. Badran, Fars K. Alanazi & Sabry M. Attia. (2018) An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects. Artificial Cells, Nanomedicine, and Biotechnology 46:4, pages 669-679.
Read now

Articles from other publishers (3)

Mehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi, Sadaf Gholami, Rasoul Raesi, Seyed Shahabadin Bidoki, Mohammad Ali Sheikh Beig Goharrizi, Yasamin Sadat Mousavi Motlagh, Ramin Khorrami, Alireza Tavakolpournegari, Noushin Nabavi, Rongjun Zou, Leila Mohammadnahal, Maliheh Entezari, Afshin Taheriazam & Kiavash Hushmandi. (2024) Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. Translational Oncology 40, pages 101846.
Crossref
Venu Sampath Kumar Golla, Prasanthi Boddu & Swathi Nageswara. (2023) Statistical Experimental Approach in Designing pH-Sensitive Oxaliplatin Lipid Nanoparticles for Application in Colorectal Cancer Therapy. BioNanoScience 13:3, pages 1100-1109.
Crossref
Asif Mohd Itoo, Milan Paul, Balaram Ghosh & Swati Biswas. (2022) Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer. Carbohydrate Polymers 282, pages 119108.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.